Seeyond’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,806
Closed -$96K 614
2022
Q3
$96K Sell
3,806
-207
-5% -$7.26K 0.01% 581
2022
Q2
$133K Sell
4,013
-81
-2% -$3.44K 0.02% 551
2022
Q1
$295K Sell
4,094
-122
-3% -$8.79K 0.03% 521
2021
Q4
$387K Buy
4,216
+3,522
+507% +$421K 0.04% 514
2021
Q3
$88K Sell
694
-8
-1% -$1.17K 0.01% 595
2021
Q2
$116K Buy
702
+3
+0.4% +$486 0.01% 584
2021
Q1
$127K Sell
699
-915
-57% -$212K 0.01% 578
2020
Q4
$322K Sell
1,614
-1,093
-40% -$222K 0.03% 512
2020
Q3
$593K Sell
2,707
-2,583
-49% -$547K 0.06% 380
2020
Q2
$1.01M Buy
+5,290
New +$927K 0.11% 255

Other funds holding TDOC

Seeyond's TDOC Position: Q4 2022 in Review

Seeyond sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 3,806 shares — an estimated $96K sold.

Seeyond first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $1.01M in Q2 2020. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Seeyond reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Seeyond sold 3,806 Teladoc Health shares in Q4 2022, an estimated $96K.
  • Seeyond first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Seeyond's Teladoc Health position peaked at $1.01M in Q2 2020.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.